array(40) {
  [0]=>
  string(4) "2483"
  ["article_id"]=>
  string(4) "2483"
  [1]=>
  string(75) "Inovio First to Advance Lassa Fever Candidate Vaccine Into a Clinical Trial"
  ["article_title"]=>
  string(75) "Inovio First to Advance Lassa Fever Candidate Vaccine Into a Clinical Trial"
  [2]=>
  string(150) "PLYMOUTH MEETING, Pa. and OSLO, Norway, May 21, 2019 /PRNewswire/ -- Inovio Pharmaceuticals, Inc. (NASDAQ: INO), together with CEPI, today announced i"
  ["short_description"]=>
  string(150) "PLYMOUTH MEETING, Pa. and OSLO, Norway, May 21, 2019 /PRNewswire/ -- Inovio Pharmaceuticals, Inc. (NASDAQ: INO), together with CEPI, today announced i"
  [3]=>
  string(247) "PLYMOUTH MEETING, Pa. and OSLO, Norway, May 21, 2019 /PRNewswire/ -- Inovio Pharmaceuticals, Inc. (NASDAQ: INO), together with CEPI, today announced it has dosed subjects in a Phase 1, first-in-human clinical trial to evaluate INO-4500, its DNA..."
  ["description"]=>
  string(247) "PLYMOUTH MEETING, Pa. and OSLO, Norway, May 21, 2019 /PRNewswire/ -- Inovio Pharmaceuticals, Inc. (NASDAQ: INO), together with CEPI, today announced it has dosed subjects in a Phase 1, first-in-human clinical trial to evaluate INO-4500, its DNA..."
  [4]=>
  NULL
  ["image"]=>
  NULL
  [5]=>
  NULL
  ["big_image"]=>
  NULL
  [6]=>
  NULL
  ["feature_images"]=>
  NULL
  [7]=>
  NULL
  ["employer_id"]=>
  NULL
  [8]=>
  string(1) "1"
  ["category"]=>
  string(1) "1"
  [9]=>
  string(3) "RSS"
  ["added_by"]=>
  string(3) "RSS"
  [10]=>
  string(2) "10"
  ["status"]=>
  string(2) "10"
  [11]=>
  NULL
  ["highlight_status"]=>
  NULL
  [12]=>
  NULL
  ["hit_count"]=>
  NULL
  [13]=>
  string(2) "15"
  ["rss_id"]=>
  string(2) "15"
  [14]=>
  string(238) "https://www.drugs.com/clinical_trials/inovio-first-advance-lassa-fever-candidate-vaccine-into-clinical-trial-18154.html?utm_source=ddc&utm_medium=rss&utm_campaign=Inovio+First+to+Advance+Lassa+Fever+Candidate+Vaccine+Into+a+Clinical+Trial"
  ["blog_url"]=>
  string(238) "https://www.drugs.com/clinical_trials/inovio-first-advance-lassa-fever-candidate-vaccine-into-clinical-trial-18154.html?utm_source=ddc&utm_medium=rss&utm_campaign=Inovio+First+to+Advance+Lassa+Fever+Candidate+Vaccine+Into+a+Clinical+Trial"
  [15]=>
  string(19) "2019-05-21 11:05:27"
  ["add_date"]=>
  string(19) "2019-05-21 11:05:27"
  [16]=>
  NULL
  ["bythe"]=>
  NULL
  [17]=>
  NULL
  ["timestamp"]=>
  NULL
  [18]=>
  string(19) "2019-05-23 14:18:33"
  ["create_at"]=>
  string(19) "2019-05-23 14:18:33"
  [19]=>
  string(0) ""
  ["slug"]=>
  string(0) ""
}
                    

array(40) {
  [0]=>
  string(4) "2484"
  ["article_id"]=>
  string(4) "2484"
  [1]=>
  string(109) "First Sublingual Ketamine Drug for Treatment of Acute Pain to be Evaluated in End-of-Phase 2 Meeting with FDA"
  ["article_title"]=>
  string(109) "First Sublingual Ketamine Drug for Treatment of Acute Pain to be Evaluated in End-of-Phase 2 Meeting with FDA"
  [2]=>
  string(150) "SINGAPORE, May 21, 2019 /PRNewswire/ -- iX Biopharma Ltd (42C.SI) announced today that following the completion of its Phase 2 clinical study on Wafer"
  ["short_description"]=>
  string(150) "SINGAPORE, May 21, 2019 /PRNewswire/ -- iX Biopharma Ltd (42C.SI) announced today that following the completion of its Phase 2 clinical study on Wafer"
  [3]=>
  string(250) "SINGAPORE, May 21, 2019 /PRNewswire/ -- iX Biopharma Ltd (42C.SI) announced today that following the completion of its Phase 2 clinical study on Wafermine, a sublingual racemic ketamine wafer for the treatment of acute moderate to severe pain, the..."
  ["description"]=>
  string(250) "SINGAPORE, May 21, 2019 /PRNewswire/ -- iX Biopharma Ltd (42C.SI) announced today that following the completion of its Phase 2 clinical study on Wafermine, a sublingual racemic ketamine wafer for the treatment of acute moderate to severe pain, the..."
  [4]=>
  NULL
  ["image"]=>
  NULL
  [5]=>
  NULL
  ["big_image"]=>
  NULL
  [6]=>
  NULL
  ["feature_images"]=>
  NULL
  [7]=>
  NULL
  ["employer_id"]=>
  NULL
  [8]=>
  string(1) "1"
  ["category"]=>
  string(1) "1"
  [9]=>
  string(3) "RSS"
  ["added_by"]=>
  string(3) "RSS"
  [10]=>
  string(2) "10"
  ["status"]=>
  string(2) "10"
  [11]=>
  NULL
  ["highlight_status"]=>
  NULL
  [12]=>
  NULL
  ["hit_count"]=>
  NULL
  [13]=>
  string(2) "15"
  ["rss_id"]=>
  string(2) "15"
  [14]=>
  string(272) "https://www.drugs.com/clinical_trials/first-sublingual-ketamine-acute-pain-evaluated-end-phase-2-meeting-fda-18152.html?utm_source=ddc&utm_medium=rss&utm_campaign=First+Sublingual+Ketamine+Drug+for+Treatment+of+Acute+Pain+to+be+Evaluated+in+End-of-Phase+2+Meeting+with+FDA"
  ["blog_url"]=>
  string(272) "https://www.drugs.com/clinical_trials/first-sublingual-ketamine-acute-pain-evaluated-end-phase-2-meeting-fda-18152.html?utm_source=ddc&utm_medium=rss&utm_campaign=First+Sublingual+Ketamine+Drug+for+Treatment+of+Acute+Pain+to+be+Evaluated+in+End-of-Phase+2+Meeting+with+FDA"
  [15]=>
  string(19) "2019-05-21 09:05:59"
  ["add_date"]=>
  string(19) "2019-05-21 09:05:59"
  [16]=>
  NULL
  ["bythe"]=>
  NULL
  [17]=>
  NULL
  ["timestamp"]=>
  NULL
  [18]=>
  string(19) "2019-05-23 14:18:33"
  ["create_at"]=>
  string(19) "2019-05-23 14:18:33"
  [19]=>
  string(0) ""
  ["slug"]=>
  string(0) ""
}
                    

array(40) {
  [0]=>
  string(4) "2602"
  ["article_id"]=>
  string(4) "2602"
  [1]=>
  string(66) "Voyager’s CSO Dinah Sah to Retire, Omar Khwaja Expands Role"
  ["article_title"]=>
  string(66) "Voyager’s CSO Dinah Sah to Retire, Omar Khwaja Expands Role"
  [2]=>
  string(150) "Dinah Sah is retiring from her position as chief scientific officer of Voyager Therapeutics (NASDAQ: VYGR). In her place, the Cambridge, MA-based gene"
  ["short_description"]=>
  string(150) "Dinah Sah is retiring from her position as chief scientific officer of Voyager Therapeutics (NASDAQ: VYGR). In her place, the Cambridge, MA-based gene"
  [3]=>
  string(352) "Dinah Sah is retiring from her position as chief scientific officer of Voyager Therapeutics (NASDAQ: VYGR). In her place, the Cambridge, MA-based gene therapy developer said that Chief Medical Officer Omar Khwaja will take on an expanded role as chief medical officer and head of research and development. The changes will happen June 28, but […]"
  ["description"]=>
  string(352) "Dinah Sah is retiring from her position as chief scientific officer of Voyager Therapeutics (NASDAQ: VYGR). In her place, the Cambridge, MA-based gene therapy developer said that Chief Medical Officer Omar Khwaja will take on an expanded role as chief medical officer and head of research and development. The changes will happen June 28, but […]"
  [4]=>
  NULL
  ["image"]=>
  NULL
  [5]=>
  NULL
  ["big_image"]=>
  NULL
  [6]=>
  NULL
  ["feature_images"]=>
  NULL
  [7]=>
  NULL
  ["employer_id"]=>
  NULL
  [8]=>
  string(1) "1"
  ["category"]=>
  string(1) "1"
  [9]=>
  string(3) "RSS"
  ["added_by"]=>
  string(3) "RSS"
  [10]=>
  string(2) "10"
  ["status"]=>
  string(2) "10"
  [11]=>
  NULL
  ["highlight_status"]=>
  NULL
  [12]=>
  NULL
  ["hit_count"]=>
  NULL
  [13]=>
  string(2) "36"
  ["rss_id"]=>
  string(2) "36"
  [14]=>
  string(96) "https://xconomy.com/boston/2019/05/20/voyagers-cso-dinah-sah-to-retire-omar-khwaja-expands-role/"
  ["blog_url"]=>
  string(96) "https://xconomy.com/boston/2019/05/20/voyagers-cso-dinah-sah-to-retire-omar-khwaja-expands-role/"
  [15]=>
  string(19) "2019-05-21 07:15:26"
  ["add_date"]=>
  string(19) "2019-05-21 07:15:26"
  [16]=>
  NULL
  ["bythe"]=>
  NULL
  [17]=>
  NULL
  ["timestamp"]=>
  NULL
  [18]=>
  string(19) "2019-05-23 14:24:09"
  ["create_at"]=>
  string(19) "2019-05-23 14:24:09"
  [19]=>
  string(0) ""
  ["slug"]=>
  string(0) ""
}
                    

array(40) {
  [0]=>
  string(4) "2603"
  ["article_id"]=>
  string(4) "2603"
  [1]=>
  string(74) "Animal Bio Picks Tufts’ Rentko for Chief Veterinary Medical Officer"
  ["article_title"]=>
  string(74) "Animal Bio Picks Tufts’ Rentko for Chief Veterinary Medical Officer"
  [2]=>
  string(150) "Ginny Rentko has been appointed chief veterinary medical officer of Animal Biosciences, a subsidiary of Boston-based Life Biosciences. Rentko comes to"
  ["short_description"]=>
  string(150) "Ginny Rentko has been appointed chief veterinary medical officer of Animal Biosciences, a subsidiary of Boston-based Life Biosciences. Rentko comes to"
  [3]=>
  string(351) "Ginny Rentko has been appointed chief veterinary medical officer of Animal Biosciences, a subsidiary of Boston-based Life Biosciences. Rentko comes to Animal Bio from Tufts University, where she was medical director of the Cummings School of Veterinary Medicine. Animal Bio is developing therapeutics and supplements intended to help pets live longer."
  ["description"]=>
  string(351) "Ginny Rentko has been appointed chief veterinary medical officer of Animal Biosciences, a subsidiary of Boston-based Life Biosciences. Rentko comes to Animal Bio from Tufts University, where she was medical director of the Cummings School of Veterinary Medicine. Animal Bio is developing therapeutics and supplements intended to help pets live longer."
  [4]=>
  NULL
  ["image"]=>
  NULL
  [5]=>
  NULL
  ["big_image"]=>
  NULL
  [6]=>
  NULL
  ["feature_images"]=>
  NULL
  [7]=>
  NULL
  ["employer_id"]=>
  NULL
  [8]=>
  string(1) "1"
  ["category"]=>
  string(1) "1"
  [9]=>
  string(3) "RSS"
  ["added_by"]=>
  string(3) "RSS"
  [10]=>
  string(2) "10"
  ["status"]=>
  string(2) "10"
  [11]=>
  NULL
  ["highlight_status"]=>
  NULL
  [12]=>
  NULL
  ["hit_count"]=>
  NULL
  [13]=>
  string(2) "36"
  ["rss_id"]=>
  string(2) "36"
  [14]=>
  string(105) "https://xconomy.com/boston/2019/05/20/animal-bio-picks-tufts-rentko-for-chief-veterinary-medical-officer/"
  ["blog_url"]=>
  string(105) "https://xconomy.com/boston/2019/05/20/animal-bio-picks-tufts-rentko-for-chief-veterinary-medical-officer/"
  [15]=>
  string(19) "2019-05-21 06:35:35"
  ["add_date"]=>
  string(19) "2019-05-21 06:35:35"
  [16]=>
  NULL
  ["bythe"]=>
  NULL
  [17]=>
  NULL
  ["timestamp"]=>
  NULL
  [18]=>
  string(19) "2019-05-23 14:24:09"
  ["create_at"]=>
  string(19) "2019-05-23 14:24:09"
  [19]=>
  string(0) ""
  ["slug"]=>
  string(0) ""
}
                    

array(40) {
  [0]=>
  string(4) "2604"
  ["article_id"]=>
  string(4) "2604"
  [1]=>
  string(67) "Reneo Pharma Launches with $50M to Target Energy-Depleting Diseases"
  ["article_title"]=>
  string(67) "Reneo Pharma Launches with $50M to Target Energy-Depleting Diseases"
  [2]=>
  string(150) "Yet another new biotech company has been founded in San Diego by serial entrepreneur Mike Grey and other alumni of rare disease startup Lumena Pharmac"
  ["short_description"]=>
  string(150) "Yet another new biotech company has been founded in San Diego by serial entrepreneur Mike Grey and other alumni of rare disease startup Lumena Pharmac"
  [3]=>
  string(334) "Yet another new biotech company has been founded in San Diego by serial entrepreneur Mike Grey and other alumni of rare disease startup Lumena Pharmaceuticals. Reneo Pharmaceuticals, which has offices in San Diego and in the UK, announced Monday it has raised $50 million to advance a compound it is testing as a therapy for […]"
  ["description"]=>
  string(334) "Yet another new biotech company has been founded in San Diego by serial entrepreneur Mike Grey and other alumni of rare disease startup Lumena Pharmaceuticals. Reneo Pharmaceuticals, which has offices in San Diego and in the UK, announced Monday it has raised $50 million to advance a compound it is testing as a therapy for […]"
  [4]=>
  NULL
  ["image"]=>
  NULL
  [5]=>
  NULL
  ["big_image"]=>
  NULL
  [6]=>
  NULL
  ["feature_images"]=>
  NULL
  [7]=>
  NULL
  ["employer_id"]=>
  NULL
  [8]=>
  string(1) "1"
  ["category"]=>
  string(1) "1"
  [9]=>
  string(3) "RSS"
  ["added_by"]=>
  string(3) "RSS"
  [10]=>
  string(2) "10"
  ["status"]=>
  string(2) "10"
  [11]=>
  NULL
  ["highlight_status"]=>
  NULL
  [12]=>
  NULL
  ["hit_count"]=>
  NULL
  [13]=>
  string(2) "36"
  ["rss_id"]=>
  string(2) "36"
  [14]=>
  string(108) "https://xconomy.com/san-diego/2019/05/20/reneo-pharma-launches-with-50m-to-target-energy-depleting-diseases/"
  ["blog_url"]=>
  string(108) "https://xconomy.com/san-diego/2019/05/20/reneo-pharma-launches-with-50m-to-target-energy-depleting-diseases/"
  [15]=>
  string(19) "2019-05-21 06:16:22"
  ["add_date"]=>
  string(19) "2019-05-21 06:16:22"
  [16]=>
  NULL
  ["bythe"]=>
  NULL
  [17]=>
  NULL
  ["timestamp"]=>
  NULL
  [18]=>
  string(19) "2019-05-23 14:24:09"
  ["create_at"]=>
  string(19) "2019-05-23 14:24:09"
  [19]=>
  string(0) ""
  ["slug"]=>
  string(0) ""
}
                    

array(40) {
  [0]=>
  string(4) "2501"
  ["article_id"]=>
  string(4) "2501"
  [1]=>
  string(69) "Judge Sides With Dana-Farber Over Cancer Immunotherapy Patent Credits"
  ["article_title"]=>
  string(69) "Judge Sides With Dana-Farber Over Cancer Immunotherapy Patent Credits"
  [2]=>
  string(153) "&#nl        The U.S. District Court in Boston has ruled that a Dana-Farber Cancer Institute scientist and a former member of the Genetics Institute deser"
  ["short_description"]=>
  string(153) "&#nl        The U.S. District Court in Boston has ruled that a Dana-Farber Cancer Institute scientist and a former member of the Genetics Institute deser"
  [3]=>
  string(234) "&#nl        The U.S. District Court in Boston has ruled that a Dana-Farber Cancer Institute scientist and a former member of the Genetics Institute deserve credit as co-inventors of six valuable cancer immunotherapy patents.&#nl      "
  ["description"]=>
  string(234) "&#nl        The U.S. District Court in Boston has ruled that a Dana-Farber Cancer Institute scientist and a former member of the Genetics Institute deserve credit as co-inventors of six valuable cancer immunotherapy patents.&#nl      "
  [4]=>
  NULL
  ["image"]=>
  NULL
  [5]=>
  NULL
  ["big_image"]=>
  NULL
  [6]=>
  NULL
  ["feature_images"]=>
  NULL
  [7]=>
  NULL
  ["employer_id"]=>
  NULL
  [8]=>
  string(1) "1"
  ["category"]=>
  string(1) "1"
  [9]=>
  string(3) "RSS"
  ["added_by"]=>
  string(3) "RSS"
  [10]=>
  string(2) "10"
  ["status"]=>
  string(2) "10"
  [11]=>
  NULL
  ["highlight_status"]=>
  NULL
  [12]=>
  NULL
  ["hit_count"]=>
  NULL
  [13]=>
  string(2) "16"
  ["rss_id"]=>
  string(2) "16"
  [14]=>
  string(109) "https://www.fdanews.com/articles/191363-judge-sides-with-dana-farber-over-cancer-immunotherapy-patent-credits"
  ["blog_url"]=>
  string(109) "https://www.fdanews.com/articles/191363-judge-sides-with-dana-farber-over-cancer-immunotherapy-patent-credits"
  [15]=>
  string(19) "2019-05-21 05:55:31"
  ["add_date"]=>
  string(19) "2019-05-21 05:55:31"
  [16]=>
  NULL
  ["bythe"]=>
  NULL
  [17]=>
  NULL
  ["timestamp"]=>
  NULL
  [18]=>
  string(19) "2019-05-23 14:18:36"
  ["create_at"]=>
  string(19) "2019-05-23 14:18:36"
  [19]=>
  string(0) ""
  ["slug"]=>
  string(0) ""
}
                    

array(40) {
  [0]=>
  string(4) "2502"
  ["article_id"]=>
  string(4) "2502"
  [1]=>
  string(53) "House Health Subcommittee Back into Drug Pricing Fray"
  ["article_title"]=>
  string(53) "House Health Subcommittee Back into Drug Pricing Fray"
  [2]=>
  string(153) "&#nl        A key House subcommittee will take its turn grilling the drug industry Tuesday as it considers seven separate pieces of legislation that back"
  ["short_description"]=>
  string(153) "&#nl        A key House subcommittee will take its turn grilling the drug industry Tuesday as it considers seven separate pieces of legislation that back"
  [3]=>
  string(211) "&#nl        A key House subcommittee will take its turn grilling the drug industry Tuesday as it considers seven separate pieces of legislation that backers say would help reduce spiraling drug prices.&#nl      "
  ["description"]=>
  string(211) "&#nl        A key House subcommittee will take its turn grilling the drug industry Tuesday as it considers seven separate pieces of legislation that backers say would help reduce spiraling drug prices.&#nl      "
  [4]=>
  NULL
  ["image"]=>
  NULL
  [5]=>
  NULL
  ["big_image"]=>
  NULL
  [6]=>
  NULL
  ["feature_images"]=>
  NULL
  [7]=>
  NULL
  ["employer_id"]=>
  NULL
  [8]=>
  string(1) "1"
  ["category"]=>
  string(1) "1"
  [9]=>
  string(3) "RSS"
  ["added_by"]=>
  string(3) "RSS"
  [10]=>
  string(2) "10"
  ["status"]=>
  string(2) "10"
  [11]=>
  NULL
  ["highlight_status"]=>
  NULL
  [12]=>
  NULL
  ["hit_count"]=>
  NULL
  [13]=>
  string(2) "16"
  ["rss_id"]=>
  string(2) "16"
  [14]=>
  string(93) "https://www.fdanews.com/articles/191362-house-health-subcommittee-back-into-drug-pricing-fray"
  ["blog_url"]=>
  string(93) "https://www.fdanews.com/articles/191362-house-health-subcommittee-back-into-drug-pricing-fray"
  [15]=>
  string(19) "2019-05-21 05:54:41"
  ["add_date"]=>
  string(19) "2019-05-21 05:54:41"
  [16]=>
  NULL
  ["bythe"]=>
  NULL
  [17]=>
  NULL
  ["timestamp"]=>
  NULL
  [18]=>
  string(19) "2019-05-23 14:18:36"
  ["create_at"]=>
  string(19) "2019-05-23 14:18:36"
  [19]=>
  string(0) ""
  ["slug"]=>
  string(0) ""
}
                    

array(40) {
  [0]=>
  string(4) "2537"
  ["article_id"]=>
  string(4) "2537"
  [1]=>
  string(118) "Align Technology General Counsel Retires After 17 Years, Appoints Julie Coletti SVP Chief Legal and Regulatory Officer"
  ["article_title"]=>
  string(118) "Align Technology General Counsel Retires After 17 Years, Appoints Julie Coletti SVP Chief Legal and Regulatory Officer"
  [2]=>
  string(150) "SAN JOSE, Calif., May  20, 2019  (GLOBE NEWSWIRE) -- Align Technology, Inc. (Nasdaq: ALGN), today announced that Roger E. George, Align senior vice pr"
  ["short_description"]=>
  string(150) "SAN JOSE, Calif., May  20, 2019  (GLOBE NEWSWIRE) -- Align Technology, Inc. (Nasdaq: ALGN), today announced that Roger E. George, Align senior vice pr"
  [3]=>
  string(660) "
SAN JOSE, Calif., May  20, 2019  (GLOBE NEWSWIRE) -- Align Technology, Inc. (Nasdaq: ALGN), today announced that Roger E. George, Align senior vice president, chief legal and regulatory officer has retired and will leave the company at the end of August 2019. Mr. George was responsible for all aspects of Align Technology's legal affairs including transactional, securities, governance, intellectual property, real estate and employment matters. Julie Coletti, Align vice president and associate general counsel, strategic commercial affairs has assumed Mr. George’s responsibilities and will work with him to ensure a smooth transition.
"
  ["description"]=>
  string(660) "
SAN JOSE, Calif., May  20, 2019  (GLOBE NEWSWIRE) -- Align Technology, Inc. (Nasdaq: ALGN), today announced that Roger E. George, Align senior vice president, chief legal and regulatory officer has retired and will leave the company at the end of August 2019. Mr. George was responsible for all aspects of Align Technology's legal affairs including transactional, securities, governance, intellectual property, real estate and employment matters. Julie Coletti, Align vice president and associate general counsel, strategic commercial affairs has assumed Mr. George’s responsibilities and will work with him to ensure a smooth transition.
"
  [4]=>
  NULL
  ["image"]=>
  NULL
  [5]=>
  NULL
  ["big_image"]=>
  NULL
  [6]=>
  NULL
  ["feature_images"]=>
  NULL
  [7]=>
  NULL
  ["employer_id"]=>
  NULL
  [8]=>
  string(1) "1"
  ["category"]=>
  string(1) "1"
  [9]=>
  string(3) "RSS"
  ["added_by"]=>
  string(3) "RSS"
  [10]=>
  string(2) "10"
  ["status"]=>
  string(2) "10"
  [11]=>
  NULL
  ["highlight_status"]=>
  NULL
  [12]=>
  NULL
  ["hit_count"]=>
  NULL
  [13]=>
  string(2) "27"
  ["rss_id"]=>
  string(2) "27"
  [14]=>
  string(188) "http://www.globenewswire.com/news-release/2019/05/20/1829163/0/en/Align-Technology-General-Counsel-Retires-After-17-Years-Appoints-Julie-Coletti-SVP-Chief-Legal-and-Regulatory-Officer.html"
  ["blog_url"]=>
  string(188) "http://www.globenewswire.com/news-release/2019/05/20/1829163/0/en/Align-Technology-General-Counsel-Retires-After-17-Years-Appoints-Julie-Coletti-SVP-Chief-Legal-and-Regulatory-Officer.html"
  [15]=>
  string(19) "2019-05-21 04:00:00"
  ["add_date"]=>
  string(19) "2019-05-21 04:00:00"
  [16]=>
  NULL
  ["bythe"]=>
  NULL
  [17]=>
  NULL
  ["timestamp"]=>
  NULL
  [18]=>
  string(19) "2019-05-23 14:23:54"
  ["create_at"]=>
  string(19) "2019-05-23 14:23:54"
  [19]=>
  string(0) ""
  ["slug"]=>
  string(0) ""
}
                    

array(40) {
  [0]=>
  string(4) "2463"
  ["article_id"]=>
  string(4) "2463"
  [1]=>
  string(60) "Statin Use Reduces Dementia Risk After Concussion in Seniors"
  ["article_title"]=>
  string(60) "Statin Use Reduces Dementia Risk After Concussion in Seniors"
  [2]=>
  string(150) "MONDAY, May 20, 2019 -- Older adults have an increased risk for dementia after concussion, which is modestly reduced among patients using a statin, ac"
  ["short_description"]=>
  string(150) "MONDAY, May 20, 2019 -- Older adults have an increased risk for dementia after concussion, which is modestly reduced among patients using a statin, ac"
  [3]=>
  string(254) "MONDAY, May 20, 2019 -- Older adults have an increased risk for dementia after concussion, which is modestly reduced among patients using a statin, according to a study published online May 20 in JAMA Neurology.&#nlDonald A. Redelmeier, M.D., from the..."
  ["description"]=>
  string(254) "MONDAY, May 20, 2019 -- Older adults have an increased risk for dementia after concussion, which is modestly reduced among patients using a statin, according to a study published online May 20 in JAMA Neurology.&#nlDonald A. Redelmeier, M.D., from the..."
  [4]=>
  NULL
  ["image"]=>
  NULL
  [5]=>
  NULL
  ["big_image"]=>
  NULL
  [6]=>
  NULL
  ["feature_images"]=>
  NULL
  [7]=>
  NULL
  ["employer_id"]=>
  NULL
  [8]=>
  string(1) "1"
  ["category"]=>
  string(1) "1"
  [9]=>
  string(3) "RSS"
  ["added_by"]=>
  string(3) "RSS"
  [10]=>
  string(2) "10"
  ["status"]=>
  string(2) "10"
  [11]=>
  NULL
  ["highlight_status"]=>
  NULL
  [12]=>
  NULL
  ["hit_count"]=>
  NULL
  [13]=>
  string(1) "6"
  ["rss_id"]=>
  string(1) "6"
  [14]=>
  string(195) "https://www.drugs.com/news/statin-reduces-dementia-risk-after-concussion-seniors-82611.html?utm_source=ddc&utm_medium=rss&utm_campaign=Statin+Use+Reduces+Dementia+Risk+After+Concussion+in+Seniors"
  ["blog_url"]=>
  string(195) "https://www.drugs.com/news/statin-reduces-dementia-risk-after-concussion-seniors-82611.html?utm_source=ddc&utm_medium=rss&utm_campaign=Statin+Use+Reduces+Dementia+Risk+After+Concussion+in+Seniors"
  [15]=>
  string(19) "2019-05-21 03:00:40"
  ["add_date"]=>
  string(19) "2019-05-21 03:00:40"
  [16]=>
  NULL
  ["bythe"]=>
  NULL
  [17]=>
  NULL
  ["timestamp"]=>
  NULL
  [18]=>
  string(19) "2019-05-23 14:18:25"
  ["create_at"]=>
  string(19) "2019-05-23 14:18:25"
  [19]=>
  string(0) ""
  ["slug"]=>
  string(0) ""
}
                    

array(40) {
  [0]=>
  string(4) "2464"
  ["article_id"]=>
  string(4) "2464"
  [1]=>
  string(56) "Racial Disparity Seen in Prescriptions for Buprenorphine"
  ["article_title"]=>
  string(56) "Racial Disparity Seen in Prescriptions for Buprenorphine"
  [2]=>
  string(150) "MONDAY, May 20, 2019 -- Black patients are less likely to receive a buprenorphine prescription to treat opioid use disorder, according to a research l"
  ["short_description"]=>
  string(150) "MONDAY, May 20, 2019 -- Black patients are less likely to receive a buprenorphine prescription to treat opioid use disorder, according to a research l"
  [3]=>
  string(253) "MONDAY, May 20, 2019 -- Black patients are less likely to receive a buprenorphine prescription to treat opioid use disorder, according to a research letter published online May 8 in JAMA Psychiatry.&#nlPooja A. Lagisetty, M.D., from the University of..."
  ["description"]=>
  string(253) "MONDAY, May 20, 2019 -- Black patients are less likely to receive a buprenorphine prescription to treat opioid use disorder, according to a research letter published online May 8 in JAMA Psychiatry.&#nlPooja A. Lagisetty, M.D., from the University of..."
  [4]=>
  NULL
  ["image"]=>
  NULL
  [5]=>
  NULL
  ["big_image"]=>
  NULL
  [6]=>
  NULL
  ["feature_images"]=>
  NULL
  [7]=>
  NULL
  ["employer_id"]=>
  NULL
  [8]=>
  string(1) "1"
  ["category"]=>
  string(1) "1"
  [9]=>
  string(3) "RSS"
  ["added_by"]=>
  string(3) "RSS"
  [10]=>
  string(2) "10"
  ["status"]=>
  string(2) "10"
  [11]=>
  NULL
  ["highlight_status"]=>
  NULL
  [12]=>
  NULL
  ["hit_count"]=>
  NULL
  [13]=>
  string(1) "6"
  ["rss_id"]=>
  string(1) "6"
  [14]=>
  string(187) "https://www.drugs.com/news/racial-disparity-seen-prescriptions-buprenorphine-82608.html?utm_source=ddc&utm_medium=rss&utm_campaign=Racial+Disparity+Seen+in+Prescriptions+for+Buprenorphine"
  ["blog_url"]=>
  string(187) "https://www.drugs.com/news/racial-disparity-seen-prescriptions-buprenorphine-82608.html?utm_source=ddc&utm_medium=rss&utm_campaign=Racial+Disparity+Seen+in+Prescriptions+for+Buprenorphine"
  [15]=>
  string(19) "2019-05-21 03:00:20"
  ["add_date"]=>
  string(19) "2019-05-21 03:00:20"
  [16]=>
  NULL
  ["bythe"]=>
  NULL
  [17]=>
  NULL
  ["timestamp"]=>
  NULL
  [18]=>
  string(19) "2019-05-23 14:18:25"
  ["create_at"]=>
  string(19) "2019-05-23 14:18:25"
  [19]=>
  string(0) ""
  ["slug"]=>
  string(0) ""
}
                    

array(40) {
  [0]=>
  string(4) "2465"
  ["article_id"]=>
  string(4) "2465"
  [1]=>
  string(56) "Readmission Rates Vary Little Among Primary Care Doctors"
  ["article_title"]=>
  string(56) "Readmission Rates Vary Little Among Primary Care Doctors"
  [2]=>
  string(150) "MONDAY, May 20, 2019 -- There is minimal variation in readmission rates among primary care providers (PCPs), according to a study published online May"
  ["short_description"]=>
  string(150) "MONDAY, May 20, 2019 -- There is minimal variation in readmission rates among primary care providers (PCPs), according to a study published online May"
  [3]=>
  string(247) "MONDAY, May 20, 2019 -- There is minimal variation in readmission rates among primary care providers (PCPs), according to a study published online May 21 in the Annals of Internal Medicine.&#nlSiddhartha Singh, M.D., from the Medical College of..."
  ["description"]=>
  string(247) "MONDAY, May 20, 2019 -- There is minimal variation in readmission rates among primary care providers (PCPs), according to a study published online May 21 in the Annals of Internal Medicine.&#nlSiddhartha Singh, M.D., from the Medical College of..."
  [4]=>
  NULL
  ["image"]=>
  NULL
  [5]=>
  NULL
  ["big_image"]=>
  NULL
  [6]=>
  NULL
  ["feature_images"]=>
  NULL
  [7]=>
  NULL
  ["employer_id"]=>
  NULL
  [8]=>
  string(1) "1"
  ["category"]=>
  string(1) "1"
  [9]=>
  string(3) "RSS"
  ["added_by"]=>
  string(3) "RSS"
  [10]=>
  string(2) "10"
  ["status"]=>
  string(2) "10"
  [11]=>
  NULL
  ["highlight_status"]=>
  NULL
  [12]=>
  NULL
  ["hit_count"]=>
  NULL
  [13]=>
  string(1) "6"
  ["rss_id"]=>
  string(1) "6"
  [14]=>
  string(194) "https://www.drugs.com/news/readmission-rates-vary-little-among-primary-care-doctors-82609.html?utm_source=ddc&utm_medium=rss&utm_campaign=Readmission+Rates+Vary+Little+Among+Primary+Care+Doctors"
  ["blog_url"]=>
  string(194) "https://www.drugs.com/news/readmission-rates-vary-little-among-primary-care-doctors-82609.html?utm_source=ddc&utm_medium=rss&utm_campaign=Readmission+Rates+Vary+Little+Among+Primary+Care+Doctors"
  [15]=>
  string(19) "2019-05-21 03:00:10"
  ["add_date"]=>
  string(19) "2019-05-21 03:00:10"
  [16]=>
  NULL
  ["bythe"]=>
  NULL
  [17]=>
  NULL
  ["timestamp"]=>
  NULL
  [18]=>
  string(19) "2019-05-23 14:18:25"
  ["create_at"]=>
  string(19) "2019-05-23 14:18:25"
  [19]=>
  string(0) ""
  ["slug"]=>
  string(0) ""
}
                    

array(40) {
  [0]=>
  string(4) "2645"
  ["article_id"]=>
  string(4) "2645"
  [1]=>
  string(63) "Wearable data collaboration gives AbbVie insight into MS trials"
  ["article_title"]=>
  string(63) "Wearable data collaboration gives AbbVie insight into MS trials"
  [2]=>
  string(150) "AbbVie is collaborating with MC10 to use its wearable system to gather insights on possible metrics and digital biomarkers that can be applied to MS t"
  ["short_description"]=>
  string(150) "AbbVie is collaborating with MC10 to use its wearable system to gather insights on possible metrics and digital biomarkers that can be applied to MS t"
  [3]=>
  string(156) "AbbVie is collaborating with MC10 to use its wearable system to gather insights on possible metrics and digital biomarkers that can be applied to MS trials."
  ["description"]=>
  string(156) "AbbVie is collaborating with MC10 to use its wearable system to gather insights on possible metrics and digital biomarkers that can be applied to MS trials."
  [4]=>
  NULL
  ["image"]=>
  NULL
  [5]=>
  NULL
  ["big_image"]=>
  NULL
  [6]=>
  NULL
  ["feature_images"]=>
  NULL
  [7]=>
  NULL
  ["employer_id"]=>
  NULL
  [8]=>
  string(1) "1"
  ["category"]=>
  string(1) "1"
  [9]=>
  string(3) "RSS"
  ["added_by"]=>
  string(3) "RSS"
  [10]=>
  string(2) "10"
  ["status"]=>
  string(2) "10"
  [11]=>
  NULL
  ["highlight_status"]=>
  NULL
  [12]=>
  NULL
  ["hit_count"]=>
  NULL
  [13]=>
  string(2) "49"
  ["rss_id"]=>
  string(2) "49"
  [14]=>
  string(169) "https://www.outsourcing-pharma.com/Article/2019/05/20/Wearable-data-collaboration-gives-AbbVie-insight-into-MS-trials?utm_source=RSS_Feed&utm_medium=RSS&utm_campaign=RSS"
  ["blog_url"]=>
  string(169) "https://www.outsourcing-pharma.com/Article/2019/05/20/Wearable-data-collaboration-gives-AbbVie-insight-into-MS-trials?utm_source=RSS_Feed&utm_medium=RSS&utm_campaign=RSS"
  [15]=>
  string(19) "2019-05-21 00:15:00"
  ["add_date"]=>
  string(19) "2019-05-21 00:15:00"
  [16]=>
  NULL
  ["bythe"]=>
  NULL
  [17]=>
  NULL
  ["timestamp"]=>
  NULL
  [18]=>
  string(19) "2019-05-23 14:24:24"
  ["create_at"]=>
  string(19) "2019-05-23 14:24:24"
  [19]=>
  string(0) ""
  ["slug"]=>
  string(0) ""
}